The Organ Protection of Astragalus in Subjects With Metabolic Syndrome
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Metabolic syndrome have the damages on tissues and organs in heart、kindey and vessels. In
this study, prospective randomized, controlled, parallel designed ,different doses of
Astragalus Mongolia, Gansu Longxi produce treat on the MS patients, and then use real-time
quantitative PCR and Western Blotting to detect the index of oxidative stress
、angiotensin-converting enzyme 2 mRNA expression and proteins.